Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Myasthenia Gravis ll: Pathophysiology01:22

Myasthenia Gravis ll: Pathophysiology

The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Autoimmune Disorders01:29

Autoimmune Disorders

Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune system...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Efficacy and safety of avacopan in patients with ANCA-associated vasculitis receiving rituximab in a randomised trial.

Annals of the rheumatic diseases·2023
Same author

Effectiveness and safety of rituximab in Takayasu arteritis: a multicenter retrospective study.

Joint bone spine·2023
Same author

European Stroke Organisation (ESO) guidelines on Primary Angiitis of the Central Nervous System (PACNS).

European stroke journal·2023
Same author

Polymyalgia rheumatica.

Lancet (London, England)·2023
Same author

Upadacitinib effectiveness and factors associated with minimal disease activity achievement in patients with psoriatic arthritis: preliminary data of a real-life multicenter study.

Arthritis research & therapy·2023
Same author

Prevalence and distribution of vascular calcifications at CT scan in patients with and without large vessel vasculitis: a matched cross-sectional study.

RMD open·2023

関連する実験動画

Updated: Jul 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

ポリミアルジア・レウマチアと巨大細胞動脈炎

Carlo Salvarani1, Fabrizio Cantini, Gene G Hunder

  • 1Unit of Rheumatology, Arcispedale S Maria Nuova, Reggio Emilia, Italy. salvarani.carlo@asmn.re.it

Lancet (London, England)
|July 22, 2008
PubMed
まとめ

ポリミアルジア・レウマチアと巨大細胞動脈炎は,関連する炎症性疾患である. グルココルチコステロイドは主な治療法ですが,長期使用は有害事象を引き起こすため,新しい治療目標が必要になります.

科学分野:

  • レウマトロジーの病理学
  • 免疫学 免疫学とは
  • 血管医学 血管医学とは

背景:

  • ポリミアルジア・レウマチア (PMR) と巨大細胞動脈炎 (GCA) は,高齢者に影響する炎症性疾患です.
  • これらの状態は,しばしば同時に発生し,未知の病因を共有し,潜在的に遺伝的および環境的要因を伴う可能性があります.
  • PMRはシナビス炎を伴うが,GCAは大動脈とその分岐に影響を及ぼし,様々な神経学的および血管的症状を呈する.

研究 の 目的:

  • ポリミアルジア・レウマチアおよび巨大細胞動脈炎に関する現在の理解をレビューする.
  • 確立された治療法とその限界について話し合う.
  • 新しい治療戦略の必要性を強調する.

主な方法:

  • ポリミアルジア・レウマチアと巨大細胞動脈炎に関する文献レビュー.
  • 臨床的表れと病原性の分析.
  • 現在の治療方法とその悪影響の評価.

主要な成果:

  • グルココルチコステロイドは,PMRとGCAの両方の主要な治療法です.
  • 長期のグルココルチコステロイド療法はしばしば必要であり,患者の50%以上で有害事象につながります.

関連する実験動画

Last Updated: Jul 3, 2026

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis
06:35

An Immunohistopathologic Study to Profile the Folate Receptor Beta Macrophage and Vascular Immune Microenvironment in Giant Cell Arteritis

Published on: February 8, 2019

  • ステロイドを節約する薬の試験は,矛盾した結果を示しています.
  • 結論:

    • PMRとGCAの分子病原性をより深く理解することは極めて重要です.
    • 新しい分子標的を特定することは,より効果的で安全な治療法の開発に不可欠です.
    • 将来の研究は,グルココルチコステロイドを超えた革新的な治療戦略に焦点を当てなければならない.